Generic Pharmaceutical Association

Biorasi joins GPhA Biosimilar Council

Wednesday, September 7, 2016

Biorasi, a CRO that optimizes trial design and delivery for sponsor organizations, is now an associate member organization of the Biosimilars Council, a division of the Generic Pharmaceutical Association (GPhA). This newly minted alliance provides Biorasi with the opportunity to work with the world’s leading-edge biosimilar developers, helping to influence policies, form best practices, and promote science-based research and findings related to biosimilar drugs. 

[Read More]

Industry associations support FDA Safety Over Sequestration Act

Wednesday, August 7, 2013

Senator Mark Pryor, chairman of the Senate Appropriations Subcommittee on Agriculture, Rural Development, FDA and Related Agencies, and Sens. Roy Blunt, Daniel Coats, Al Franken and Jerry Moran last week introduced S. 1413 to exempt future FDA user fees from sequestration. A similar bill, H.R. 2725, was introduced in the U.S. House of Representatives earlier this month by Representatives Leonard Lance, Anna Eshoo, Mike Rogers and Doris Matsui.

[Read More]